secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001823239-24-000124
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences Chairman Carl Hull Retires; R. Andrew Eckert Appointed Chairman
--------------------------------------------------------------------------------

- Founder Carl Hull retires as Executive Chairman and resigns from Board, effective Dec 5, 2024; departure not related to any disagreement.
- R. Andrew Eckert unanimously elected Chairman of the Board, effective Dec 5, 2024; he is a healthcare industry veteran with prior executive roles.
- Eckert receives annual cash retainer of $175,000 (starting Jan 1, 2025) and RSU awards with total grant date fair value of $1.25M, subject to vesting.
- Initial RSU award of $750K vests one-third immediately, remainder at 2025 annual meeting and one year later; second award of $500K expected at 2025 annual meeting.
- Carl Hull founded Maravai in 2014, served as CEO until Oct 2022 when he became Executive Chairman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000124/0001823239-24-000124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323924000124/mrvi-20241203.htm
  HTML page:      https://secwatch.observer/filing/0001823239-24-000124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer